BY27 is a potent and selective BET BD2 inhibitor, shows 38, 5, 7, and 21-fold BD1/BD2 selectivity for BRD2, BRD3, BRD4, and BRDT. Anti-cancer activity[1].
Molecular Weight:
404.90
CAS Number:
[2247236-59-3]
Formula:
C22H21ClN6
Target:
Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted